149 related articles for article (PubMed ID: 36703095)
1. Innate differences in the molecular signature of normal inferior & superior human parathyroid glands: potential implications for parathyroid adenoma.
Agarwal S; Kar P; Boruah M; Saha S; Millo T; Kumar C; Vuthaluru S; Goswami R
Mol Cell Biochem; 2023 Oct; 478(10):2351-2359. PubMed ID: 36703095
[TBL] [Abstract][Full Text] [Related]
2. Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism.
Sadowski SM; Pusztaszeri M; Brulhart-Meynet MC; Petrenko V; De Vito C; Sobel J; Delucinge-Vivier C; Kebebew E; Regazzi R; Philippe J; Triponez F; Dibner C
J Clin Endocrinol Metab; 2018 Jun; 103(6):2189-2198. PubMed ID: 29659895
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians.
Varshney S; Bhadada SK; Saikia UN; Sachdeva N; Behera A; Arya AK; Sharma S; Bhansali A; Mithal A; Rao SD
Eur J Endocrinol; 2013 Jul; 169(1):109-16. PubMed ID: 23660642
[TBL] [Abstract][Full Text] [Related]
4. CaSR expression in normal parathyroid and PHPT: new insights into pathogenesis from an autopsy-based study.
Agarwal S; Kardam S; Chatterjee P; Kumar C; Boruah M; Sharma MC; Tabin M; Ramakrishnan L
J Endocrinol Invest; 2022 Feb; 45(2):337-346. PubMed ID: 34302683
[TBL] [Abstract][Full Text] [Related]
5. First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation.
Giusti L; Cetani F; Da Valle Y; Pardi E; Ciregia F; Donadio E; Gargini C; Piano I; Borsari S; Jaber A; Caputo A; Basolo F; Giannaccini G; Marcocci C; Lucacchini A
J Cell Mol Med; 2014 Oct; 18(10):1944-52. PubMed ID: 25164318
[TBL] [Abstract][Full Text] [Related]
6. Global and gene-specific promoter methylation analysis in primary hyperparathyroidism.
Sulaiman L; Juhlin CC; Nilsson IL; Fotouhi O; Larsson C; Hashemi J
Epigenetics; 2013 Jun; 8(6):646-55. PubMed ID: 23764768
[TBL] [Abstract][Full Text] [Related]
7. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
8. [Morphology of the parathyroid glands. A study of 146 samples and review of the literature].
Pino Rivero V; Pantoja Hernández CG; Mora Santos ME; González Palomino A; Pardo Romero G; Gómez de Tejada Romero R; Blasco Huelva A
An Otorrinolaringol Ibero Am; 2007; 34(2):135-42. PubMed ID: 17549960
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles in parathyroid adenoma and normal parathyroid tissue.
Kim SW
Vitam Horm; 2022; 120():289-304. PubMed ID: 35953114
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
[TBL] [Abstract][Full Text] [Related]
12. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
13. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
14. Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism.
Correa P; Akerström G; Westin G
Clin Endocrinol (Oxf); 2002 Oct; 57(4):501-5. PubMed ID: 12354132
[TBL] [Abstract][Full Text] [Related]
15. The anatomy of primary hyperparathyroidism.
Thompson NW; Eckhauser FE; Harness JK
Surgery; 1982 Nov; 92(5):814-21. PubMed ID: 7135202
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
[TBL] [Abstract][Full Text] [Related]
17. Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor.
Koh J; Dar M; Untch BR; Dixit D; Shi Y; Yang Z; Adam MA; Dressman H; Wang X; Gesty-Palmer D; Marks JR; Spurney R; Druey KM; Olson JA
Mol Endocrinol; 2011 May; 25(5):867-76. PubMed ID: 21393447
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid tumors and related disorders.
DeLellis RA
Mod Pathol; 2011 Apr; 24 Suppl 2():S78-93. PubMed ID: 21455204
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological correlates of hyperparathyroidism.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
[TBL] [Abstract][Full Text] [Related]
20. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
